The beliefs, and reported and intended behaviors of unaffected men in response to their family history of prostate cancer

Cowan, Ruth Schwartz; Meiser, Bettina; Giles, Graham G.; Lindeman, Geoffrey J.; Gaff, Clara

doi:10.1097/gim.0b013e31817701c1

Cited by 10 publications

(15 citation statements)

References 54 publications

(59 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nine studies were conducted in the USA; 185,186,189,192,[194][195][196][197]199 one of these was colocated in Puerto Rico; 185 five were conducted in the UK, [167][168][169][170][171] three in Australia, 190,193,198 two in Canada 187,188 and one in Germany. 191 Thirteen studies evaluated adults' views concerning the taking of vitamins and minerals, 169,185,187,[189][190][191][192][193][195][196][197][198][199] five studies considered aspirin or NSAIDs, [168][169][170][171]194 two folic acid 167,185 and two dietary supplements generally. 186,188 Only four studies explored the views of participants who had either a cancer diagnosis 186,197,…”

Section: Resultsmentioning

confidence: 99%

“…[185][186][187][188][189][190][191][192][193][194] Five further studies were identified by unstructured searching. [195][196][197][198][199] In total, 20 studies were included. For details of the search and selection process, see the flow diagram of studies ( Figure 12).…”

Section: Resultsmentioning

confidence: 99%

“…191 Thirteen studies evaluated adults' views concerning the taking of vitamins and minerals, 169,185,187,[189][190][191][192][193][195][196][197][198][199] five studies considered aspirin or NSAIDs, [168][169][170][171]194 two folic acid 167,185 and two dietary supplements generally. 186,188 Only four studies explored the views of participants who had either a cancer diagnosis 186,197,199 or a family history of cancer, 198 but 10 of the other included studies did focus specifically on either prevention alone 167 or the long-term management of chronic conditions, which included elements of prevention, including arthritis, 170,194 heart disease, 192,193 renal problems, 188 type 2 diabetes, 196 or a range of conditions. 168,187,191 Most studies used interviews and/or focus groups to elicit people's opinions and views on the taking of the relevant agents; 167,168,170,[185][186]…”

Section: Resultsmentioning

confidence: 99%

“…168,187,191 Most studies used interviews and/or focus groups to elicit people's opinions and views on the taking of the relevant agents; 167,168,170,[185][186][187]189,190,[193][194][195][196] eight studies used structured surveys or questionnaires. 169,171,188,191,192,[197][198][199] The 15 studies identified by the initial search came from six different databases: EMBASE, 168,169,171,187 AMED, 189,191,193,194 MEDLINE,190,192 MEDLINE InProcess & Other Non-Indexed Citations, 167,170,185 CINAHL, 188 and the Science and Social Science Citation Index. 186 This is typical of findings regarding the distribution and degree of dispersal of social science and qualitative studies.…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Chemoprevention of colorectal cancer: systematic review and economic evaluation

Cooper

Squires²,

Carroll³

et al. 2010

Health Technol Assess

184

182

View full text Add to dashboard Cite

How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below).Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order:-fax (with credit card details) -post (with credit card details or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows:Synergie UK (HTA Department) Digital House, The Loddon Centre Wade Road Basingstoke Hants RG24 8QW Email: orders@hta.ac.uk Tel: 0845 812 4000 -ask for 'HTA Payment Services' (out-of-hours answer-phone service) Fax: 0845 812 4001 -put 'HTA Order' on the fax header Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address. Paying by credit cardYou can order using your credit card by phone, fax or post. SubscriptionsNHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40-50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume. How do I get a copy of HTA on DVD?Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment programmeT he Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of project...

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Chemoprevention of colorectal cancer: systematic review and economic evaluation

Cooper

Squires²,

Carroll³

et al. 2010

Health Technol Assess

184

182

View full text Add to dashboard Cite

show abstract

“…However, this would be successful only if patients were willing to trust negative screen results, given a prevailing culture that seems to promote higher levels of screening as "better" screening practice. [75][76][77] Thus, SNP-based screening panels need to demonstrate increased specificity, and may also need to demonstrate superior levels of sensitivity, compared with PSA-based screening for patients and their physicians to have confidence in their use, especially in view of the debate about PSA-based screening. 18,[78][79][80] Some studies have suggested that the use of SNP-based models in stratifying PSA thresholds could improve PSA-based screening.…”

Section: Discussionmentioning

confidence: 99%

Multigene panels in prostate cancer risk assessment: a systematic review

Little

Wilson

Carter

et al. 2016

Genetics in Medicine

View full text Add to dashboard Cite

Prostate cancer is the fourth most common malignancy worldwide, and the second most common among men.1 In 2014, it was estimated that more than a quarter of a million new cases were diagnosed in North America and that the disease accounted for more than 33,000 deaths. 2,3 These numbers are likely to increase with the aging of the population. On the basis of data from the Surveillance, Epidemiology, and End Results program, more men were diagnosed with prostate cancer at a younger age and earlier stage in 2004-2005 than in the mid-late 1990s, and disparity between ethnic groups in cancer stage at diagnosis decreased. 4 Apart from age, 5 ethnic group, 5,6 and family history, 7-9 the risk factors associated with prostate cancer are unclear, 5 making primary prevention difficult. Prostate cancer is currently considered to be a complex, multifactorial disease, and the vast majority of familial clustering is attributed to the interaction of multiple shared susceptibility genes with moderate to low penetrance and shared environmental factors within these families.The natural history of prostate cancer is highly variable. 10 In a large proportion of men the disease is indolent, and it is difficult to predict which tumors will be aggressive. The value of aggressive management for localized prostate cancer is debated, [11][12][13][14] and only a small proportion of men with early-stage prostate cancer die from the disease within 10 to 15 years of diagnosis. Developing tools to differentiate aggressive and indolent disease is of key importance.Prostate-specific antigen (PSA) screening was introduced in the late 1980s.15 Meta-analyses of seven randomized controlled trials (RCTs) of screening using PSA testing alone or in combination with digital rectal examination suggested no evidence of benefit in reducing mortality 16,17 and some evidence of harm from overdiagnosis.17 Amid substantial debate, 18-20 the argument has been made for developing more accurate screening tests, including possible genetic markers. Purpose: Single-nucleotide polymorphism (SNP) panel tests have been proposed for use in the detection of, and prediction of risk for, prostate cancer and as prognostic indicator in affected men. A systematic review was undertaken to address three research questions to evaluate the analytic validity, clinical validity, clinical utility, and prognostic validity of SNP-based panels.Methods: Data sources comprised MEDLINE, Cochrane CEN-TRAL, Cochrane Database of Systematic Reviews, and EMBASE; these were searched from inception to April 2013. The gray-literature searches included contact with manufacturers. Eligible studies included English-language studies evaluating commercially available SNP panels. Study selection and risk of bias assessment were undertaken by two independent reviewers. Results:Twenty-one studies met eligibility criteria. All focused on clinical validity and evaluated 18 individual panels with 2 to 35 SNPs.All had poor discriminative ability (overall area under receiver-operator characteristic curves, 5...

show abstract

Monitoring style of coping with cancer related threats: a review of the literature

Roussi

Miller

2014

J Behav Med

View full text Add to dashboard Cite

Building on the Cognitive-Social Health Information-Processing model, this paper provides a theoretically guided review of monitoring (i.e., attend to and amplify) cancer-related threats. Specifically, the goals of the review are to examine whether individuals high on monitoring are characterized by specific cognitive, affective, and behavioral responses to cancer-related health threats than individuals low on monitoring and the implications of these cognitive-affective responses for patient-centered outcomes, including patient-physician communication, decision-making and the development of interventions to promote adherence and adjustment. A total of 74 reports were found, based on 63 studies, 13 of which were intervention studies. The results suggest that although individuals high on monitoring are more knowledgeable about health threats, they are less satisfied with the information provided. Further, they tend to be characterized by greater perceived risk, more negative beliefs, and greater value of health-related information and experience more negative affective outcomes. Finally, individuals high on monitoring tend to be more demanding of the health providers in terms of desire for more information and emotional support, are more assertive during decision-making discussions, and subsequently experience more decisional regret. Psychoeducational interventions improve outcomes when the level and type of information provided is consistent with the individual's monitoring style and the demands of the specific health threat. Implications for patient-centered outcomes, in terms of tailoring of interventions, patient-provider communication, and decision-making, are discussed.

show abstract

The beliefs, and reported and intended behaviors of unaffected men in response to their family history of prostate cancer

Abstract: Participants commonly believed behavioral factors influenced prostate cancer risk and reported that they would alter their behavior to reduce risk after (hypothetical) genetic testing.

Cited by 10 publications

References 54 publications

Chemoprevention of colorectal cancer: systematic review and economic evaluation

Chemoprevention of colorectal cancer: systematic review and economic evaluation

Multigene panels in prostate cancer risk assessment: a systematic review

Monitoring style of coping with cancer related threats: a review of the literature

Contact Info

Product

Resources

About